Sector: MedicalImClone Systems Incorporated (NASDAQ: IMCL)
Headlines
- Carl Icahn V. Amylin Pharmacueticals Inc.
Apr 20, 2009 06:16 PM | AMLN, IMCL, LLY, NVO
- Best Performing Stocks Of The Past Quarter
Dec 04, 2008 09:43 AM | ADM, ALO, APOL, ASBC, CNX, CXG
- Weekly Mergers and Acquisitions Report (11-17-08 to 11-21-2008)
Nov 24, 2008 08:59 AM | AW, BHP, BRCD, CTL, EQ, FDRY
- Pharmaceuticals Industry
Nov 21, 2008 04:22 PM | ABT, AMLN, ARNA, BIIB, BMY, DNA
- Lilly Coughs It Up for ImClone - Analyst Blog
Oct 28, 2008 10:12 AM | IMCL, LLY
- Weekly Mergers and Acquisitions Report - Oct 21 2008 9:08AM
Oct 21, 2008 08:56 AM | ALO, AWH, BRL, BUD, DR, DRS
- Initial Analysis : ImClone Systems (IMCL) - Eli Lilly (LLY) Merger
Oct 14, 2008 08:08 PM | IMCL, LLY
- Weekly Mergers and Acquisitions Report - Oct 7 2008 9:55AM
Oct 07, 2008 09:24 AM | ANR, AW, BAC, BHP, BMY, CLF
- Monday Meltdown Again
Oct 06, 2008 08:25 PM | IMCL, LLY
- US Stock Futures Slide On Economic Concerns, Credit Woes
Oct 06, 2008 09:21 AM | AZ, C, IMCL, KO, LLY
- Eli Lilly Increases Earnings 21 Percent in Second Quarter
Jul 22, 2009 05:01 PM | IMCL, LLY
- Movers: Wells Fargo, Wachovia, Citigroup, ImClone, eBay
Oct 07, 2008 10:55 AM | BAC, BMY, C, DNA, EBAY, HIG
- More Economists See U.S. In, Near Recession
Oct 07, 2008 07:56 AM | AAPL, BMY, IMCL, RIMM
- Movers: GE, ImClone Systems, Ford, AIG, Boston Scientific
Oct 02, 2008 10:56 AM | AIG, ATU, BSX, CYH, DBD, EBS
- Movers: AIG, WaMu, Circuit City, Lennar, GE
Sep 24, 2008 10:51 AM | AIG, APD, BAC, BMY, C, CACH
- Movers: Exxon Mobil, WaMu, ImClone Systems, Marathon Oil, Disney, MasterCard
Aug 01, 2008 10:53 AM | AET, AKAM, BARE, BMY, CBS, DIS
- S&P Picks and Pans: Exxon Mobil, Disney, Starbucks, MasterCard, Bristol-Myers Squibb, Tyco
Aug 01, 2008 10:53 AM | DIS, IMCL, SBUX, TYC, XOM
- Movers: Wells Fargo, Merrill Lynch, Microsoft, Intel, Seagate, Alpha Natural Resources
Jul 17, 2008 10:53 AM | ABT, AEO, ALTR, AMR, ANR, ASML
- NASDAQ OMX and Leerink Swann to Co-Host Healthcare Industry Forum - Nov 25 2008 11:22AM
Nov 25, 2008 11:00 AM | ATHN, HSIC, IMCL, MDRX, MRK, NDAQ
- Lilly Completes Cash Tender Offer for ImClone Systems
Nov 21, 2008 08:24 AM | IMCL, LLY
- ImClone Systems’ State-of-the-Art Manufacturing Facility Receives FDA Approval for Multi-Product Biologics Production
Nov 20, 2008 07:09 AM | IMCL
- Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced
Breast Cancer Commences Patient Enrollment
Nov 19, 2008 07:03 AM | IMCL
- ImClone Systems Announces Clearance of Tender Offer by German Federal
Cartel Office
Nov 17, 2008 06:31 PM | IMCL
- Phase 2 Study of IMC-1121B in First-Line Treatment of Advanced Non-Small Cell Lung Cancer Commences Patient Enrollment
Nov 11, 2008 07:03 AM | IMCL
- ImClone Systems Announces Expiration of Hart-Scott-Rodino Waiting Period
Nov 05, 2008 08:05 AM | IMCL
- ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
Oct 29, 2008 07:12 AM | IMCL
- Study Published in New England Journal of Medicine Shows K-ras Gene Mutation Status May Affect Response to ERBITUX(R) Treatment
Oct 22, 2008 05:01 PM | BMY, IMCL
- Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Oct 14, 2008 08:04 AM | IMCL, LLY
- Form 4 Rowinsky Eric K For: Nov 24 (10K)
Nov 26, 2008 04:25 PM
- Form 4 IMCLONE SYSTEMS INC For: Nov 24 Filed by: Schloss David (10K)
Nov 26, 2008 04:24 PM
- Form 4 IMCLONE SYSTEMS INC For: Nov 24 Filed by: Ehmer Bernhard (10K)
Nov 26, 2008 04:21 PM
- Form 4 Powell Andrew Kenneth For: Nov 24 (10K)
Nov 26, 2008 04:20 PM
- Form 4 Johnson John H For: Nov 24 (10K)
Nov 26, 2008 04:20 PM
- Form 4 DePinto Joseph I For: Nov 24 (10K)
Nov 26, 2008 04:20 PM
- Form 4 Denner Alexander J For: Nov 24 (10K)
Nov 25, 2008 04:38 PM
- Form 4 Rowinsky Eric K For: Nov 21 (10K)
Nov 24, 2008 05:13 PM
- Form 4 IMCLONE SYSTEMS INC For: Nov 21 Filed by: Schloss David (10K)
Nov 24, 2008 04:54 PM
- Form 4 Johnson John H For: Nov 21 (10K)
Nov 24, 2008 04:54 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
IMCL
|
Compare to S&P
|
| YTD |
-0.01 %
|
-0.01 %
|
| 4 Weeks |
-0.01 %
|
-0.01 %
|
| 12 Weeks |
-0.01 %
|
-0.01 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -164.52 %
|
|
EPS Growth in Last Year: -154.05 %
|
|
Sales Growth in Last Quarter: -0.87 %
|
|
Sales Growth in Last Quarter: 11.87 %
|
|
